• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virology. Homologous recombination evidence in human and swine influenza A viruses.

Giuseppe

Emeritus
Virology. 2008 Aug 20. [Epub ahead of print]

Homologous recombination evidence in human and swine influenza A viruses.

He CQ, Han GZ, Wang D, Liu W, Li GR, Liu XP, Ding NZ. - College of Life Science, Shandong Normal University, Shandong Province, Jinan 250014, China.

Dynamic gene mutation and the reassortment of genes have been considered as the key factors responsible for influenza A virus virulence and host tropism change.

This study reports several significant evidence demonstrating that homologous recombination also takes place between influenza A viruses in human and swine lineages.

Moreover, in a mosaic descended from swine H1N1 subtype and human H2N2, we found that its minor putative parent might be a derivative from the human cold-adapted vaccine lineage, which suggests that live vaccine is capable of playing a role in genetic change of influenza A virus via recombination with circulating viruses.

These results would be important for knowing the molecular mechanism of mammal influenza A virus heredity and evolution.
-
PMID: 18721995 [PubMed - as supplied by publisher
-------
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

Homologous recombination evidence in human and swine influenza A viruses
<!-- articleText -->Cheng-Qiang He<SUP>a</SUP><SUP>, </SUP><SUP></SUP><SUP>, </SUP><SUP></SUP>, Guan-Zhu Han<SUP>a</SUP>, Dong Wang<SUP>a</SUP>, Wei Liu<SUP>c</SUP>, Guo-Rong Li<SUP>a</SUP>, Xi-Ping Liu<SUP>a</SUP> and Nai-Zheng Ding<SUP>b</SUP><SUP>, </SUP><SUP></SUP><SUP>, </SUP><SUP></SUP>
<SUP>a</SUP>College of Life Science, Shandong Normal University, Shandong Province, Jinan 250014, China <SUP>b</SUP>College of Life Science, Central South University, Changsha 410012, China <SUP>c</SUP>Laboratory of Molecular Biology, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
<!-- articleText -->
Received 14 March 2008;
<!-- graphText, refText -->revised 6 May 2008;
<!-- graphText, refText -->accepted 15 July 2008.
<!-- graphText, refText -->Available online 21 August 2008.
<!-- articleText -->


<!-- articleText -->Abstract

Dynamic gene mutation and the reassortment of genes have been considered as the key factors responsible for influenza A virus virulence and host tropism change. This study reports several significant evidence demonstrating that homologous recombination also takes place between influenza A viruses in human and swine lineages. Moreover, in a mosaic descended from swine H1N1 subtype and human H2N2, we found that its minor putative parent might be a derivative from the human cold-adapted vaccine lineage, which suggests that live vaccine is capable of playing a role in genetic change of influenza A virus via recombination with circulating viruses. These results would be important for knowing the molecular mechanism of mammal influenza A virus heredity and evolution.

<!-- articleText -->Keywords: Influenza A virus; Homologous recombination; Vaccine

<!-- articleText -->Article Outline

<DL><DT>Introduction <DT>Results and discussion <DL><DT>A/swine/Ontario/57561/03(H1N1) <DT>A/swine/Ontario/53518/03(H1N1)</DT></DL><DT>Methods <DT>Acknowledgements <DT>Appendix A. Supplementary data <DT>References</DT></DL>
<!-- articleText -->
Introduction

Influenza viruses threaten significantly both human and animal health. In the last hundred years, several influenza pandemics were responsible for the deaths of at least 40 million people (Horimoto and Kawaoka, 2005). Recently, a highly pathogenic avian influenza virus (AIV; H5N1) has resulted in the death of more than 200 people and the slaughter of millions of poultry in Asia, Europe and Africa, raising concern over the possibility of a new influenza pandemic among the world's immunologically naive populations (Horimoto and Kawaoka, 2005).
The virus belongs to the Orthomyxoviridae family and contains eight segments of single-stranded RNA (ssRNA) which encode 11 proteins, PB2, PB1, PB1-F2, PA, HA, NP, NA, M1, M2, NS1 and NS2 (Nelson and Holmes, 2007). These segments allow for the swapping and exchange of gene segments between different strains. Specifically it occurs when the human influenza viruses swap their HA glycoprotein, NA glycoprotein or polymerase (PB1, PB2, PA) segments with those of avian and pig Influenza A viruses. Although the origin of the H1N1 strain that caused the severe pandemic of 1918 is less clear and the source of much debate ([Antonovics et al., 2006], [Gibbs and Gibbs, 2006] and [Taubenberger et al., 2005]), reassortment among HA and NA subtypes was fundamental in the human pandemics of 1957 (H2N2 subtype) and 1968 (H3N2 subtype), which also acquired a new basic polymerase 1 (PB1) segment (Lindstrom et al., 2004).
A key molecular basis that drives the virulence change of a virus is amino acid mutation. Dynamic gene mutant has been shown to play an important role in the virulence change of AIV ([Hatta et al., 2001] and [Hulse-Post et al., 2007]), but homologous recombination also plays an important role in the evolution of some RNA viruses ([Kirkegaard and Baltimore, 1986], [Lai, 1992] and [Nagy and Simon, 1997]). Virulent variants of some other viruses have been generated by homologous recombination ([Anderson et al., 2000], [Kew et al., 2002], [Pita et al., 2001] and [Worobey et al., 1999]). For influenza A virus, there has been ample evidence that influenza viruses undergo various forms of non-homologous recombination. For example, a recombination can occur between HA and nucleoprotein gene (Orlich et al., 1994). Similarly, increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus was also found (Khatchikian et al., 1989). However, the occurrence of homologous recombination within segments is far from proven (Nelson and Holmes, 2007).
In order to clarify whether homologous recombination drives the evolution of human influenza A, we analyzed the H1N1 subtype of about 3800 genes and found several significant evidences of recombination between swine H1N1 and human H2N2 subtypes in PA, between swine lineage strains in PB2, and between human lineage strains in HA and NP. Particularly, in a mosaic PA of swine H1N1, one putative parent seems to be derived from a cold-adapted avirulent vaccine lineage of human H2N2. These data show that the intragenic recombination can indeed play a role in driving the evolution of influenza A virus. In addition, the avirulent vaccine could shape the evolution of the virus via homologous recombination with circulating influenza A virus.
Results and discussion

We performed different segment comparisons of available H1N1 subtype sequences (total 3815 complete gene segment sequences, HA, 485; NA, 472; PA, 459; PB1, 467; PB2, 457; M, 478; NS, 476; NP, 521) to find evidence of recombination between influenza A and to identify potential breakpoints for any such events. Among 3815 complete genes of influenza A, at least four mosaics were found (Table 1). In particular, the natural recombinant A/swine/Ontario/57561/03(H1N1) (DQ280191) is descended from swine H1N1 and human H2N2 in the gene PA. The results show that the homologous recombination can drive mammal influenza A virus evolution, and might result in potential change of virus virulence and host tropism.

Table 1.
Influenza A virus strains with significant evidence for recombination
<TABLE style="FONT-SIZE: 0.95em" cellSpacing=0 cellPadding=6 rules=groups border=1 frame=hsides><COLGROUP span=7><COL><COL><COL><COL><COL><COL><COL><THEAD><TR><TH vAlign=top align=left>No.</TH><TH vAlign=top align=left>Accession no.</TH><TH vAlign=top align=left>Mosaic virus strain</TH><TH vAlign=top align=left>Gene</TH><TH vAlign=top align=left>Putative parent lineages</TH><TH vAlign=top align=left>Breakpoint(s)</TH><TH vAlign=top align=left>pSH</TH></TR></THEAD><TBODY><TR><TD class=nowrap vAlign=top align=left>1</TD><TD class=nowrap vAlign=top align=left>DQ280191</TD><TD class=nowrap vAlign=top align=left>A/swine/Ontario/57561/03(H1N1)</TD><TD class=nowrap vAlign=top align=left>PA</TD><TD class=nowrap vAlign=top align=left>A/swine/Ontario/55383/04(H1N2)</TD><TD class=nowrap vAlign=top align=left>515</TD><TD class=nowrap vAlign=top align=left>< 0.001</TD></TR><TR><TD class=nowrap headers=col1></TD><TD class=nowrap headers=col2></TD><TD class=nowrap headers=col3></TD><TD class=nowrap headers=col4></TD><TD class=nowrap vAlign=top align=left>A/Ann Arbor/6/1960(H2N2)</TD><TD class=nowrap headers=col6></TD><TD class=nowrap headers=col7></TD></TR><TR><TD class=nowrap vAlign=top align=left>2</TD><TD class=nowrap vAlign=top align=left>DQ280213</TD><TD class=nowrap vAlign=top align=left>A/Swine/Ontario/53518/03</TD><TD class=nowrap vAlign=top align=left>PB2</TD><TD class=nowrap vAlign=top align=left>A/Swine/Korea/CY02/02(H1N2)</TD><TD class=nowrap vAlign=top align=left>538</TD><TD class=nowrap vAlign=top align=left>< 0.001</TD></TR><TR><TD class=nowrap headers=col1></TD><TD class=nowrap headers=col2></TD><TD class=nowrap headers=col3></TD><TD class=nowrap headers=col4></TD><TD class=nowrap vAlign=top align=left>A/swine/Alberta/56626/03(H1N1)</TD><TD class=nowrap headers=col6></TD><TD class=nowrap headers=col7></TD></TR><TR><TD class=nowrap vAlign=top align=left>3</TD><TD class=nowrap vAlign=top align=left>DQ415318</TD><TD class=nowrap vAlign=top align=left>A/Taiwan/4845/99(H1N1)</TD><TD class=nowrap vAlign=top align=left>HA</TD><TD class=nowrap vAlign=top align=left>A/WSN/33(H1N1)</TD><TD class=nowrap vAlign=top align=left>136, 623, 960</TD><TD class=nowrap vAlign=top align=left>< 0.001</TD></TR><TR><TD class=nowrap headers=col1></TD><TD class=nowrap headers=col2></TD><TD class=nowrap headers=col3></TD><TD class=nowrap headers=col4></TD><TD class=nowrap vAlign=top align=left>A/Wellington/24/2000(H1N1)</TD><TD class=nowrap headers=col6></TD><TD class=nowrap headers=col7></TD></TR><TR><TD class=nowrap vAlign=top align=left>4</TD><TD class=nowrap vAlign=top align=left>AF255749</TD><TD class=nowrap vAlign=top align=left>A/Hong Kong/498/97(H3N2)</TD><TD class=nowrap vAlign=top align=left>NP</TD><TD class=nowrap vAlign=top align=left>A/Hong Kong/427/98(H1N1)</TD><TD class=nowrap vAlign=top align=left>223</TD><TD class=nowrap vAlign=top align=left>< 0.01</TD></TR><TR><TD class=nowrap headers=col1></TD><TD class=nowrap headers=col2></TD><TD class=nowrap headers=col3></TD><TD class=nowrap headers=col4></TD><TD class=nowrap vAlign=top align=left>A/Hong Kong/497/97(H3N2)</TD><TD class=nowrap headers=col6></TD><TD class=nowrap headers=col7></TD></TR></TBODY></TABLE>
<!-- tblScroll-->Full-size table
<!-- tblScrollLink-->
<!-- tblScrollBox-->Note. pSH indicates probability of Shimodaira?Hasegawa test.

View Within Article
<!--ViewWithinBtn-->


<!--graphTextOnly-->
<!--graphText-->
A/swine/Ontario/57561/03(H1N1)

Recently, Karasin et al. (2006) reported three novel genotypes of H1 influenza viruses recovered from pigs in Ontario of Canada. Reassortment between influenza viruses was found to be the cause resulting in these novel genotypes (Karasin et al., 2006). These viruses were isolated from pigs that ranged in age from 3-week-old nursery piglets to adult sows and that exhibited various clinical signs typical of swine influenza illness (Karasin et al., 2006). They were passaged no more than once beyond initial isolation before sequencing (Karasin et al., 2006). Their sequences were checked multiple times and determined using multiple primer pairs to be sure that none of the reported sequences were artifacts (personal communication to Prof. Olsen CW). Among these viruses, A/swine/Ontario/57561/03(H1N1) and A/swine/Ontario/53518/03(H1N1) were suspected as intragenic recombinants in PA and PB2 segment respectively.
We conducted a similarity analysis using A/swine/Ontario/57561/03(H1N1) as a query. The standard similarity plot, constructed using all sites, reveals that the PA sequence exhibits greater affinity with the influenza A human lineage than the swine lineage in the region from position 1 to 548 (Fig. 1A). On the contrary, the mosaic shares higher sequence similarity with the swine lineage than the human lineage in the region from 549 to 2147. The incongruent phylogenetic trees incorporating the avian lineage provide a robust, informative test of the recombination hypothesis (Worobey et al., 2002). When the maximum likelihood trees separated by position 548 were constructed, a significant discrepancy (Shimodaira?Hasegawa test, p < 0.001) between phylogenetic trees constitutes a powerful evidence for recombination in A/swine/Ontario/57561/03(H1N1) (Figs. 1C and D).

<HR>



<TABLE><TBODY><TR><TD width="10%"> <TD vAlign=bottom>Full-size image (154K)
High-quality image (1445K)</TD></TR></TBODY></TABLE><TABLE><TBODY><TR><TD width="10%"> <TD vAlign=bottom>Full-size image (131K)
High-quality image (1145K)</TD></TR></TBODY></TABLE><TABLE><TBODY><TR><TD width="10%"> <TD vAlign=bottom>Full-size image (90K)
High-quality image (822K)</TD></TR></TBODY></TABLE>
Fig. 1. The evidences for recombination in PA gene of the strain A/swine/Ontario/57561/03(H1N1). A, PA similarity from SimPlot analysis of A/swine/Ontario/57561/03(H1N1) is shown. Comparison of influenza A strain A/swine/Ontario/57561/03(H1N1) with the swine and human influenza A strains. The y-axis gives the percentage of similarity within a sliding window of 200 bp wide centered on the position plotted, with a step size between plots of 20 bp. B?D, phylogenetic trees for PA genes. The relationships of nucleotide sequences of the PA gene derived from humans, pigs and birds are indicated by an unrooted tree constructed using the ML method, implemented in the Phyml as described in Methods. The values of bootstrap are shown below or above the branch, respectively. The scale corresponds to the number of nucleotide substitutions per site in all trees. Only bootstrap values more than 70% are shown on each branch. The GenBank number of each segment is also listed after its name. B, the phylogenetic tree of complete PA ORF. C, the phylogenetic tree of the region from position 1 to 548. D, the phylogenetic tree of the region from position 549 to 2147. E?H, identification of recombination breakpoints in detail. E, similarity plot as in Fig. 1A with a window size of 200 bp and a step size of 20 bp. Vertical lines indicate the breakpoint identified by maximization of χ<SUP>2</SUP> and sample Akaike Information Criterion as described in Methods. Comparison of the strain A/swine/Ontario/57561/03(H1N1) with putative parents A/Ann Arbor/6/60 and A/swine/Ontario/55383/04(H1N2) is shown in E. The rest is the same as Fig. 1A. F, the result of Bootscaning. The y-axis gives the percentage of permutated trees using a sliding window of 200 bp wide centered on the position plotted, with a step size between plots of 20 bp. DE-R49/99 was used as the outgroup to determine the breakpoints. G and H are the ML phylogenies inferred for the 2 regions delimited by the informative-site analysis as described in Methods.

View Within Article
<!--viewwithinbtn-->


<!--graphTextOnly-->
<!--graphText-->
Because two cold-adapted avirulent H2N2 vaccines, A/Ann Arbor/6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were not included in our data initially, we were puzzled when its putative minor parent of the mosaic virus was identified. We found the region from nucleotide 1 to 548 of the mosaic strain fell into the subgroup of H2N2 isolated from 1957 to 1968 in phylogenetic tree. However, the mosaic strain was isolated in 2003. PA gene of human H2N2 was estimated to have evolved at rates of 2.49 ? 10 <SUP>− 3</SUP> ns/s/year (R<SUP>2</SUP> = 0.92) (Lindstrom et al., 2004). The sequence similarity between the mosaic isolated in 2003 and the H2N2 group isolated in 1960s should be about 90%. However, we found that the mosaic shared nearly 99% sequence similarity with some strains isolated in 1968. It would suggest that the putative parent of the mosaic had nearly no evolution during the 45 years when it circulated in the field, and this could not be true. A hypothesis would be that the minor parent has been descended from an avirulent vaccine of H2N2. In agreement, when the two vaccines A/Ann Arbor/6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were incorporated into the phylogenetic trees, the mosaic strain came forth in the lineage of H2N2 vaccines (Fig. 1C). The avirulent vaccine A/Ann Arbor/6/60 shares the highest sequence similarity (99.45%, 543/546) with the mosaic strain from position 1 to 546 among all isolates deposited in the GenBank. A CAIV-T (tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann Arbor/6/60 ([Gruber, 2002] and [Herlocher et al., 1993]) has been licensed in the US since 2003, suggesting that it might be shed by the vaccinees in the Ontario region and act as the putative minor parent of the mosaic. Therefore, we proposed that the putative minor parent of the mosaic might have descended from the lineage of the avirulent vaccine of human H2N2. This finding also suggested that the avirulent vaccine of human influenza A was able to shape the genetic diversity of the virus via homologous recombination with circulating viruses.
After the putative parents were identified, further recombination analyses were carried out to determine the potential breakpoints. A single breakpoint was located in a parsimonious region from 511?542 with the maximization of χ<SUP>2</SUP> using the program SimPlot. The most likely breakpoint was found exactly at site 515 according to Single Breakpoint Analysis in GARD (Figs. 1E?H).
A/swine/Ontario/53518/03(H1N1)

In a previous study, A/Swine/Ontario/53518/03 was found to be a human?swine reassortant in PB1 that exhibited various clinical signs typical of swine influenza illness (Karasin et al., 2006). It is very interesting that its PB2 is also an intragenic mosaic (Fig. 2).
We conducted a similarity analysis using A/Swine/Ontario/53518/03 as a query. The standard similarity plot reveals that the PB2 sequence exhibits greater affinity with the swine influenza A virus H1N1 subgroup than the H1N2 subgroup from position 1 to 537 (Fig. 1A). On the contrary, the mosaic shares higher sequence similarity with the swine H1N2 subgroup than the H1N1 subgroup from position 537 to 2273. A significant discrepancy between phylogenetic trees inferred for nucleotide sequences of each recombination region was found (Shimodaira?Hasegawa test, p < 0.001) when the maximum composite likelihood trees were constructed incorporating the human lineage (Figs. 2B?D). These results constitute powerful evidences for PB2 mosaic in A/swine/Ontario/57561/03(H1N1) descended from swine H1N1 and H1N2 influenza A virus.

<HR>



<TABLE><TBODY><TR><TD width="10%"> <TD vAlign=bottom>Full-size image (140K)
High-quality image (1294K)</TD></TR></TBODY></TABLE><TABLE><TBODY><TR><TD width="10%"> <TD vAlign=bottom>Full-size image (189K)
High-quality image (1812K)</TD></TR></TBODY></TABLE>
Fig. 2. The evidences for recombination in PB2 gene of the strain A/swine/Ontario/53518/03(H1N1). A, comparison of PB2 of influenza A virus strain A/swine/Ontario/53518/03(H1N1) with all swine influenza A strains listed in Fig. 2B. The y-axis gives the percentage of identity within a sliding window of 200 bp wide centered on the position plotted, with a step size between plots of 20 bp. B, ML phylogenetic tree for full-length open reading frame (ORF) of PB2 incorporating the human lineage. The tree was constructed as described in Methods. And the rest is the same as Fig.1B. C, the phylogenetic tree of the region from position 1 to 538. D, the phylogenetic tree of the region from position 539 to 2273. E, sequence similarity comparison of the mosaic strain with its putative parents, A/swine/Alberta/56626/03(H1N1) and A/Swine/Korea/CY02/02(H1N2). The red vertical line shows the recombination breakpoints with the maximization of χ<SUP>2</SUP>. F, bootscanning of PB2 of the mosaic and its parents. The y-axis gives the percentage of permutated trees using a sliding window of 200 bp wide centered on the position plotted, with a step size between plots of 20 bp. The strain A/Memphis/3/1983(H1N1) was used as outgroup. The rest is the same as E.

View Within Article
<!--viewwithinbtn-->


<!--graphTextOnly-->
<!--graphText-->
To find the putative parents of A/Swine/Ontario/53518/03, we performed BLAST using PB2 of A/Swine/Ontario/53518/03 as a query in the GenBank and found that A/swine/Alberta/56626/03 shared the highest sequence similarity with the mosaic gene from position 1 (initial code) to 537. Interestingly, an isolate from Korea A/Swine/Korea/CY02/02 shared the highest sequence similarity with the mosaic from nt 537 to 2273. This suggested the existence of a global reservoir of influenza A virus. Therefore, we proposed that the two strains might be the putative parents of the mosaic. The comparisons between the mosaic and its putative parents are shown in Figs. 2E and F. A breakpoint, from position 537 to 540 was found in PB2 gene of A/swine/Ontario/53518/03(H1N1) by maximization of χ<SUP>2</SUP> and Findsites sub-program of Simplot Program. And running the GARD online, the exact breakpoint was located in position 538. The mosaic PB2 shares 100% sequence similarity with A/swine/Alberta/56626/03 (versus 84.34% with A/Swine/Korea/CY02/02) from nt 1 to 538. However, from nt 539 to 2237, it also shares 99.89% sequence similarity with A/Swine/Korea/CY02/02 (versus 82.86% with A/swine/Alberta/56626/03). These analyses determined further that the PB2 of A/swine/Ontario/53518/03 is an intragenic recombinant.
In this study, we analyzed 3815 segment sequences of mammalian influenza A virus (equal to about 440 complete genomes) and only found 4 mosaic strains (Table 1). It means that the frequency of intragenic recombination is not high in mammalian influenza A virus. However, intragenic recombination happens indeed between different or same subtype viruses; although the recombination has always been ignored in influenza A virus. Recombination, like point mutation and reassortment, can also produce novel virus variants and results in increased virulence ([Anderson et al., 2000], [Kew et al., 2002] and [Worobey et al., 1999]). Here, we find that recombination can occur in PB2 and PA, HA (between human H1N1 subtype strains) and NP (between human H1N1 subtype strain and H3N2 subtype strain) (Table 1). The virulence of influenza A viruses is associated with their HA ([Horimoto and Kawaoka, 1994], [Perdue et al., 1997] and [Senne et al., 1996]). Mutations in the HA gene have produced highly pathogenic strains, and the major pandemics of 1957 and 1968 might be largely caused by the introduction of antigenically novel HA genes from bird-infecting influenzas ([Khatchikian et al., 1989] and [Subbarao et al., 1998]). Additionally, the polymerase complex genes were also found to contribute to the high virulence of the human H5N1 influenza virus (Salomon et al., 2006). And PB2 mutation is responsible for the virulence change in AIV (Hatta et al., 2001). If recombination happens in genes responsible for virulence and host tropism, its potential effect on the change of virulence and host tropism might be fatal.
Reassortment and recombination processes will allow some viruses to acquire many of the key adaptive mutations in a single step and hence make a major leap in fitness space (Kuiken et al., 2006), which might result in a change of host tropism of the virus. A reassortment of gene segments between pig and human influenza virus has occurred creating an entirely novel Influenza A virus strain capable of infecting humans (Steinhauer and Skehel, 2002), and might result in a population that is entirely immunologically naive to these novel viruses in human being (Russell and Webster, 2005). Similarly, the intragenic recombination between influenza virus swine lineage and human lineage is also capable of creating a novel swine lineage virus readily adaptable to human hosts. Especially, the recombination occurring in polymerase complex between human and swine influenza A virus might more easily result in a novel virus adapting to human since the viral heterotrimeric polymerase complex is considered having a role in host specificity ([Gabriel et al., 2005] and [Taubenberger et al., 2005]). Therefore, the possibility of a recombination event triggering a pandemic by altering gene structure or function and/or by permitting the virus to switch hosts from some other mammal into humans should not to be neglected.
Live vaccine derived from an A/Leningrad/134/47/57 (H2N2) master strain, a cold-adapted H2N2 strain (Rudenko et al., 1993), has been used in Russia and other countries. Avirulent vaccine CAIV-T (tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann Arbor/6/60 has been licensed in the US. The advent of live attenuated cold-adapted influenza virus vaccine (CAIV-T) administered intranasally may provide a convenient and effective alternative approach for influenza immunization (Gruber, 2002). However, since live vaccine strains are potentially released into the environment by vaccinees, safety issues concerning medical as well as environmental aspects must be considered. An important aspect concerns the exchange of genetic information between the vaccine of interest and another vaccine or wild-type strains of the carrier organism. Here, we found the natural recombinant which might be derived from a live vaccine strain. It suggests that live avirulent vaccine can play some and perhaps a very important role in speeding up the evolution of influenza A virus. It has been reported that a mosaic bovine viral diarrhea virus between a persisting pestivirus and a vaccine strain was a cytopathogenic virus that induced lethal diseases (Becher et al., 2001). And there have been recent polio epidemics in Hispaniola that arose from similar recombinants involving vaccine virus and other endogenous enteroviruses, which threatens the entire WHO polio eradication program (Kew et al., 2002). Therefore, it might be necessary to evaluate the effect of various vaccine recombination on influenza A virus virulence and host tropism. From an environmental perspective, inactivated influenza A vaccine should be safer.
In conclusion, our study provided powerful evidence that intragenic recombination occurs in mammalian influenza A viruses from different species, which shows that homologous recombination may play a role in driving the evolution of mammalian influenza A viruses and has the potential to change their virulence and host tropism. Finally, our results suggest that live vaccine is capable of speeding up viral evolution via recombination with circulating viruses.
Methods

We collected all the H1N1 subtype genes (total 3815 complete gene sequences, HA, 485; NA, 472; PA, 459; PB1, 467; PB2, 457; M, 478; NS, 476; NP, 521) that are deposited in the GenBank and analyzed their homologous recombination in the study. Multialignment was finished by using CLUSTALW (Thompson et al., 2003). Gaps were removed before further analyses were carried out. The neighbor-joining (NJ) phylogenetic tree was generated using the maximum composite likelihood (MCL) model implementing Mega4 (Tamura et al., 2007). Maximum Likelihood trees were also constructed to determine the recombination events using Phyml online tool (Guindon and Gascuel, 2003) (http://atgc.lirmm.fr/phyml/). The trees were tested using bootstrap (1000 replications). Putative recombinant sequences were identified with the SimPlot program (Lole et al., 1999). Shimodaira?Hasegawa test was implemented to prove whether phylogenetic trees estimated from different regions are significantly different employing Treetest program (http://aix1.uottawa.ca/
223c.gif
sarisbro/). The putative parents were searched using putative mosaic as a query by BLAST in the GenBank. Recombination breakpoints were analyzed by maximization of χ<SUP>2</SUP> using SimPlot combined with Akaike Information Criterion (AIC) (AICc) (Kosakovsky Pond et al., 2006). The recombination events were also further analyzed using GARD (Genetic Algorithm Recombination Detection) online (http://www.datamonkey.org/GARD/) (Kosakovsky Pond et al., 2006).

<!-- articleText -->Acknowledgments

We would like to thank Prof. Chris Olsen (University of Wisconsin?Madison) for the important information of the two isolates A/swine/Ontario/57561/03(H1N1) and A/swine/Ontario/53518/03(H1N1).

<!-- articleText -->References


Anderson et al., 2000 J.P. Anderson, A.G. Rodrigo, G.H. Learn, A. Madan, C. Delahunty, M. Coon, M. Girard, S. Osmanov, L. Hood and J.I. Mullins, Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E, J. Virol. 74 (22) (2000), pp. 10752?10765. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (34)


Antonovics et al., 2006 J. Antonovics, M.E. Hood and C.H. Baker, Molecular virology: was the 1918 flu avian in origin?, Nature 440 (7088) (2006), p. E9 discussion E9?10. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (10)


Becher et al., 2001 P. Becher, M. Orlich and H.J. Thiel, RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease, J. Virol. 75 (14) (2001), pp. 6256?6264. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (48)


Gabriel et al., 2005 G. Gabriel, B. Dauber, T. Wolff, O. Planz, H.D. Klenk and J. Stech, The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host, Proc. Natl. Acad. Sci. U. S. A. 102 (51) (2005), pp. 18590?18595. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (57)


Gibbs and Gibbs, 2006 M.J. Gibbs and A.J. Gibbs, Molecular virology: was the 1918 pandemic caused by a bird flu?, Nature 440 (7088) (2006), p. E8 discussion E9?10. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (15)


Gruber, 2002 W.C. Gruber, The role of live influenza vaccines in children, Vaccine 20 (Suppl. 2) (2002), pp. S66?S73. Article | PDF (152 K) | View Record in Scopus | Cited By in Scopus (8)


Guindon and Gascuel, 2003 S. Guindon and O. Gascuel, A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood, Syst. Biol. 52 (5) (2003), pp. 696?704. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (1430)


Hatta et al., 2001 M. Hatta, P. Gao, P. Halfmann and Y. Kawaoka, Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses, Science 293 (5536) (2001), pp. 1840?1842. Full Text via CrossRef


Herlocher et al., 1993 M.L. Herlocher, H.F. Maassab and R.G. Webster, Molecular and biological changes in the cold-adapted ?master strain? A/AA/6/60 (H2N2) influenza virus, Proc. Natl. Acad. Sci. U. S. A. 90 (13) (1993), pp. 6032?6036. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (19)


Horimoto and Kawaoka, 1994 T. Horimoto and Y. Kawaoka, Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus, J. Virol. 68 (5) (1994), pp. 3120?3128. View Record in Scopus | Cited By in Scopus (76)


Horimoto and Kawaoka, 2005 T. Horimoto and Y. Kawaoka, Influenza: lessons from past pandemics, warnings from current incidents, Nat. Rev. Microbiol. 3 (8) (2005), pp. 591?600. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (95)


Hulse-Post et al., 2007 D.J. Hulse-Post, J. Franks, K. Boyd, R. Salomon, E. Hoffmann, H.L. Yen, R.J. Webby, D. Walker, T.D. Nguyen and R.G. Webster, Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks, J. Virol. 81 (16) (2007), pp. 8515?8524. View Record in Scopus | Cited By in Scopus (6)


Karasin et al., 2006 A.I. Karasin, S. Carman and C.W. Olsen, Identification of human H1N2 and human?swine reassortant H1N2 and H1N1 influenza A viruses among pigs in Ontario, Canada (2003 to 2005), J. Clin. Microbiol. 44 (3) (2006), pp. 1123?1126. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (13)


Kew et al., 2002 O. Kew, V. Morris-Glasgow, M. Landaverde, C. Burns, J. Shaw, Z. Garib, J. Andre, E. Blackman, C.J. Freeman, J. Jorba, R. Sutter, G. Tambini, L. Venczel, C. Pedreira, F. Laender, H. Shimizu, T. Yoneyama, T. Miyamura, H. van Der Avoort, M.S. Oberste, D. Kilpatrick, S. Cochi, M. Pallansch and C. de Quadros, Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus, Science 296 (5566) (2002), pp. 356?359. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (184)


Khatchikian et al., 1989 D. Khatchikian, M. Orlich and R. Rott, Increased viral pathogenicity after insertion of a 28S ribosomal RNA sequence into the haemagglutinin gene of an influenza virus, Nature 340 (6229) (1989), pp. 156?157. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (68)


Kirkegaard and Baltimore, 1986 K. Kirkegaard and D. Baltimore, The mechanism of RNA recombination in poliovirus, Cell 47 (3) (1986), pp. 433?443. Article | PDF (2296 K) | View Record in Scopus | Cited By in Scopus (143)


Kosakovsky Pond et al., 2006 S.L. Kosakovsky Pond, D. Posada, M.B. Gravenor, C.H. Woelk and S.D. Frost, Automated phylogenetic detection of recombination using a genetic algorithm, Mol. Biol. Evol. 23 (10) (2006), pp. 1891?1901. Full Text via CrossRef


Kuiken et al., 2006 T. Kuiken, E.C. Holmes, J. McCauley, G.F. Rimmelzwaan, C.S. Williams and B.T. Grenfell, Host species barriers to influenza virus infections, Science 312 (5772) (2006), pp. 394?397. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (44)


Lai, 1992 M.M. Lai, RNA recombination in animal and plant viruses, Microbiol. Rev. 56 (1) (1992), pp. 61?79. View Record in Scopus | Cited By in Scopus (260)


Lindstrom et al., 2004 S.E. Lindstrom, N.J. Cox and A. Klimov, Genetic analysis of human H2N2 and early H3N2 influenza viruses, 1957?1972: evidence for genetic divergence and multiple reassortment events, Virology 328 (1) (2004), pp. 101?119. Abstract | PDF (1858 K) | View Record in Scopus | Cited By in Scopus (20)


Lole et al., 1999 K.S. Lole, R.C. Bollinger, R.S. Paranjape, D. Gadkari, S.S. Kulkarni, N.G. Novak, R. Ingersoll, H.W. Sheppard and S.C. Ray, Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination, J. Virol. 73 (1) (1999), pp. 152?160. View Record in Scopus | Cited By in Scopus (416)


Nagy and Simon, 1997 P.D. Nagy and A.E. Simon, New insights into the mechanisms of RNA recombination, Virology 235 (1) (1997), pp. 1?9. Abstract | PDF (573 K) | View Record in Scopus | Cited By in Scopus (164)


Nelson and Holmes, 2007 M.I. Nelson and E.C. Holmes, The evolution of epidemic influenza, Nat. Rev. Genet. 8 (3) (2007), pp. 196?205. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (14)


Orlich et al., 1994 M. Orlich, H. Gottwald and R. Rott, Nonhomologous recombination between the hemagglutinin gene and the nucleoprotein gene of an influenza virus, Virology 204 (1) (1994), pp. 462?465. Abstract | PDF (200 K) | View Record in Scopus | Cited By in Scopus (27)


Perdue et al., 1997 M.L. Perdue, M. Garcia, D. Senne and M. Fraire, Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses, Virus Res. 49 (2) (1997), pp. 173?186. Abstract | PDF (748 K) | View Record in Scopus | Cited By in Scopus (63)


Pita et al., 2001 J.S. Pita, V.N. Fondong, A. Sangare, G.W. Otim-Nape, S. Ogwal and C.M. Fauquet, Recombination, pseudorecombination and synergism of geminiviruses are determinant keys to the epidemic of severe cassava mosaic disease in Uganda, J. Gen. Virol. 82 (Pt 3) (2001), pp. 655?665. View Record in Scopus | Cited By in Scopus (76)


Rudenko et al., 1993 L.G. Rudenko, A.N. Slepushkin, A.S. Monto, A.P. Kendal, E.P. Grigorieva, E.P. Burtseva, A.R. Rekstin, A.L. Beljaev, V.E. Bragina and N. Cox et al., Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia, J. Infect. Dis. 168 (4) (1993), pp. 881?887. View Record in Scopus | Cited By in Scopus (58)


Russell and Webster, 2005 C.J. Russell and R.G. Webster, The genesis of a pandemic influenza virus, Cell 123 (3) (2005), pp. 368?371. Article | PDF (101 K) | View Record in Scopus | Cited By in Scopus (27)


Salomon et al., 2006 R. Salomon, J. Franks, E.A. Govorkova, N.A. Ilyushina, H.L. Yen, D.J. Hulse-Post, J. Humberd, M. Trichet, J.E. Rehg, R.J. Webby, R.G. Webster and E. Hoffmann, The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04, J. Exp. Med. 203 (3) (2006), pp. 689?697. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (51)


Senne et al., 1996 D.A. Senne, B. Panigrahy, Y. Kawaoka, J.E. Pearson, J. Suss, M. Lipkind, H. Kida and R.G. Webster, Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential, Avian. Dis. 40 (2) (1996), pp. 425?437. View Record in Scopus | Cited By in Scopus (116)


Steinhauer and Skehel, 2002 D.A. Steinhauer and J.J. Skehel, Genetics of influenza viruses, Annu. Rev. Genet. 36 (2002), pp. 305?332. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (25)


Subbarao et al., 1998 K. Subbarao, A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda and N. Cox, Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness, Science 279 (5349) (1998), pp. 393?396. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (491)


Tamura et al., 2007 K. Tamura, J. Dudley, M. Nei and S. Kumar, MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0, Mol. Biol. Evol. 24 (8) (2007), pp. 1596?1599. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (180)


Taubenberger et al., 2005 J.K. Taubenberger, A.H. Reid, R.M. Lourens, R. Wang, G. Jin and T.G. Fanning, Characterization of the 1918 influenza virus polymerase genes, Nature 437 (7060) (2005), pp. 889?893. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (224)


Thompson et al., 2003 W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, N. Cox, L.J. Anderson and K. Fukuda, Mortality associated with influenza and respiratory syncytial virus in the United States, Jama 289 (2) (2003), pp. 179?186. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (634)


Worobey et al., 1999 M. Worobey, A. Rambaut and E.C. Holmes, Widespread intra-serotype recombination in natural populations of dengue virus, Proc. Natl. Acad. Sci. U. S. A. 96 (13) (1999), pp. 7352?7357. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (90)


Worobey et al., 2002 M. Worobey, A. Rambaut, O.G. Pybus and D.L. Robertson, Questioning the evidence for genetic recombination in the 1918 "Spanish flu" virus, Science 296 (2002) (5566), 211 discussion 211.


<!-- refText -->Appendix A. Supplementary data
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

hmm, posted 30.Sept., thanks, but why do I not remember this ?
did I miss it or did I forget it ?
So the live attenuated vaccine is responsible for
many homologuous recombinations ?
And these are more carelessly being used in swine ?
That would explain the often simultaneously observed preservations
of regions.
But viruses recombine and die, no example that recombination
changed the evolution of flu.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

no mention of the 1977 Tennessee swine sequences. Were they used for life-vaccine too ?
Also several recombinations in several segments. How do they explain that ?
And how did the Canadian swine in 2003 come into contact with a H2N2 vaccine ?



from:
http://www.setbb.com/fluwiki2/viewtopic.php?t=243&mforum=fluwiki2

Code:
PA : 00000000000  2588 Sw/Ontario/57561/03(H1N1)      346 Singapore/57(H2N2) 
NP : 0000000004902  4623 swine/Ontario/53518/03(H1N1)            334 Swine/Nebraska/209/98(H3N2) 
PA : 00000000003  2591 Sw/Ontario/53518/03(H1N1)     3582 Sw/Tennessee/26/1977(H1N1) 
PB2 : 0000000000000  2626 Sw/Ontario/53518/03(H1N1)      89 Sw/Texas/4199-2/98 (H3N2) 
HA : 00000000012  1508 TW/4845/99(H1N1)                240 HK/1131/98 (H1N1) 
PB2 : 0000000008766  3679 HK/498/97(H3N2)              5140 Albany/1/1976(H3N2) 
NP : 0000000000142971832   345 HK/498/97(H3N2)                        1248 NY/136/02(H3N2)



preservations of segments in 2 of the putative parent viruses (coincidence ?) :

Code:
PB1: only 8 mutations in 7 years (2272)   A/swine/Ontario/53518/03(H1N1)   A/Fukushima/114/96
PB1: only 21 mutations in 22 years (2274)   A/swine/Ontario/4/1981(H1N1)   A/swine/Alberta/56626/03(H1N1)
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

hmm, posted 30.Sept., thanks, but why do I not remember this ?
did I miss it or did I forget it ?
So the live attenuated vaccine is responsible for
many homologuous recombinations ?
And these are more carelessly being used in swine ?
That would explain the often simultaneously observed preservations
of regions.
But viruses recombine and die, no example that recombination
changed the evolution of flu.
Please. The recombination between closely related sequences creates drift, which is the driver of influenza evolution.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

prove it !
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

they only considered H1

so here are my recombinations involving H1:
19 decimal digits of the p-value, some of the first digits may be omitted, when they are zero

Code:
PB2:0000000000000  2626 Sw/Ontario/53518/03(H1N1)      89 Sw/Texas/4199-2/98 (H3N2) 
PB2:0000003273490  2625 Sw/Ontario/55383/04(H1N2)    3643 Sw/Tennessee/24/1977(H1N1) 
PB2:0000214655866  2628 Sw/Ontario/48235/04(H1N2)    1168 Sw/Tennessee/25/1977(H1N1) 
PB2:0013226932138  2630 Sw/Ontario/11112/04(H1N1)    2629 Sw/Ontario/23866/04(H1N1) 
PA : 11086338434  2594 Sw/Ontario/23866/04(H1N1)     1141 Sw/Tennessee/25/1977(H1N1) 
PA:00000000000  2588 Sw/Ontario/57561/03(H1N1)      346 Singapore/57(H2N2) 
PA:00000000003  2591 Sw/Ontario/53518/03(H1N1)     3582 Sw/Tennessee/26/1977(H1N1) 
PA:00031983551  2589 Sw/Alberta/56626/03(H1N1)     3594 Sw/1976/1931(H1N1) 
PA:00084007856  2590 Sw/Ontario/55383/04(H1N2)     2593 Sw/Ontario/48235/04(H1N2) 
NP:0000000004902  4623 swine/Ontario/53518/03(H1N1)            334 Swine/Nebraska/209/98(H3N2) 

NS:p=0.0000000000000000379  1005 Sw/Korea/S10/04(H1N1)      1007 Sw/Korea/S175/04(H1N1) 
NA:p=0.0000000000000015321  2251/Sw/Alberta/56626/03(H1N1)              2139/WI/4754/1994(H1N1) 
NA:p=0.0000000010867351972  2474/Fort Monmouth/1/47(H1N1)                180/Rhodes/47(H1N1) 

HA:00000000012  1508 TW/4845/99(H1N1)                240 HK/1131/98 (H1N1) 
HA:00133851183   460 Texas/36/91(H1N1)               461 Beijing/262/95(H1N1) 

NP:00000000004902  4623 swine/Ontario/53518/03(H1N1)            334 Swine/Nebraska/209/98(H3N2)
NP:0000002992080   411 Swine/Iowa/930/01(H1N2)                 407 Swine/Ohio/891/01(H1N2) 
M:000000077004189   283/Dk/HK/P50/97(H11N9)                    3511/Western Australia/18/01(H1N1) 
NA:0000002241211655  2477 Sw/Cotes_d'Armor/1515/99(H1N1)         2752/Qa/Shantou/1821/00(H6N1) 
NA:000000000000000  3526/Moscow/346/03(H3N2)                       3/Sw/Miyagi/5/03(H1N2)


Code:
  2589 Sw/Alberta/56626/03(H1N1)     3594 Sw/1976/1931(H1N1)
..............................................................................................................
..........................................o.......................................o....o......................
................o..............o........o.....................................................................
....................................................................o.........................................
...........................o..................................................................................
......................o.......................................................................................
.....o........................................................................................................
...........................................................o...o..o...........o...............................
...............................o.........o.....................................o...........o.....o............
...............o................o.........o.......oo.............o...o........oo...o....................o.....
........................o..............o.....o..o...........o....................oo...................o..oo...
..........o....o.................................o......o.......o....................o.....oo.................
..........................o...........o...........o...........................................................
...o.....o........o...................................o..............o........................................
....o..........................o..............o...................................oo.o..................o.....
..............o....................o..o........o.....o..o..............o.......................o...........o..
......o..........................o.....o..oo....o........o.....o.....o........oo..o........o.o.....o........o.
..........o..o........o........o.....o..o.....o..............o.........o....................o.................
........o..o........o..o..o..o..............o..o...........o..........oo...o..................................
.....................o................................o......
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

looking at table 1, the putative parents are from later years
than their children ("mosaic strain")


maybe the Canadian swine got a large cocktail of
live vaccine with all sorts of strains ???


there are _many_ clear proofs for reassortments which spread
and affects flu-evolution.
Why not for recombination ?


the H2N2-vaccine : do they give old unused human vaccines to swine ?
But why H2 ?? Maybe accidently confused vaccine-bottles ? Or contamination ?
There was hardly any of the old H2 around in humans or pigs since 1969
Well, this is PA not HA, and PA was transferred to H3N2 in the 1968 pandemic.
But all those 1968 viruses had acquired mutations in PA since 1960,
A/Ann Arbor/6/1960 cannot have survived the 1968 pandemic



link to the Karasin et.al paper about Canadian Swine:
http://jcm.asm.org/cgi/content/full/44/3/1123


> These nine reassortant H1N1 viruses were isolated between October 2003 and February 2005
> from pigs on nine independent swine farms located over an 80-by-85-square-mile region of Ontario,

they don't tell us, where this was.
Theoretically there is permafrost in Ontario, where the virus or parts of it may have survived :
Southwestern Hudson Bay area. Maybe the permafrost-area was reduced between 1960 and 2003,
and pigs got the viruses from melted 1960-frozen-grounds ?
Well, doesn't sound likely : 9 pig-farms in 80 square-miles in (former) permafrost-country
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

looking at table 1, the putative parents are from later years
than their children ("mosaic strain")


maybe the Canadian swine got a large cocktail of
live vaccine with all sorts of strains ???


there are _many_ clear proofs for reassortments which spread
and affects flu-evolution.
Why not for recombination ?


the H2N2-vaccine : do they give old unused human vaccines to swine ?
But why H2 ?? Maybe accidently confused vaccine-bottles ? Or contamination ?
There was hardly any of the old H2 around in humans or pigs since 1969
Well, this is PA not HA, and PA was transferred to H3N2 in the 1968 pandemic.
But all those 1968 viruses had acquired mutations in PA since 1960,
A/Ann Arbor/6/1960 cannot have survived the 1968 pandemic



link to the Karasin et.al paper about Canadian Swine:
http://jcm.asm.org/cgi/content/full/44/3/1123


> These nine reassortant H1N1 viruses were isolated between October 2003 and February 2005
> from pigs on nine independent swine farms located over an 80-by-85-square-mile region of Ontario,

they don't tell us, where this was.
Theoretically there is permafrost in Ontario, where the virus or parts of it may have survived :
Southwestern Hudson Bay area. Maybe the permafrost-area was reduced between 1960 and 2003,
and pigs got the viruses from melted 1960-frozen-grounds ?
Well, doesn't sound likely : 9 pig-farms in 80 square-miles in (former) permafrost-country
Please. There is NO data that these sequences came from vaccines. They in fact match 1977 sequences from Tennessee as note in Nature Precedings.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

the 57561 at least was assumed to have come from an H2N2 vaccine
in the paper (He et.al) :

---------------
A hypothesis would be that the minor parent has been descended from an avirulent vaccine of H2N2. In agreement, when the two vaccines A/Ann Arbor/6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were incorporated into the phylogenetic trees, the mosaic strain came forth in the lineage of H2N2 vaccines (Fig. 1C). The avirulent vaccine A/Ann Arbor/6/60 shares the highest sequence similarity (99.45%, 543/546) with the mosaic strain from position 1 to 546 among all isolates deposited in the GenBank. A CAIV-T (tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann Arbor/6/60 ([Gruber, 2002] and [Herlocher et al., 1993]) has been licensed in the US since 2003, suggesting that it might be shed by the vaccinees in the Ontario region and act as the putative minor parent of the mosaic. Therefore, we proposed that the putative minor parent of the mosaic might have descended from the lineage of the avirulent vaccine of human H2N2. This finding also suggested that the avirulent vaccine of human influenza A was able to shape the genetic diversity of the virus via homologous recombination with circulating viruses.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

1976 was the year of "swine flu". I would not be surprised if they had been experimenting with all sorts of vaccines at that time.
I.e. in swine
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

1976 was the year of "swine flu". I would not be surprised if they had been experimenting with all sorts of vaccines at that time.
I.e. in swine
Please. The recombination is in swine, not humans.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

the 57561 at least was assumed to have come from an H2N2 vaccine
in the paper (He et.al) :

---------------
A hypothesis would be that the minor parent has been descended from an avirulent vaccine of H2N2. In agreement, when the two vaccines A/Ann Arbor/6/1960(H2N2) and A/Leningrad/134/47/57(H2N2) were incorporated into the phylogenetic trees, the mosaic strain came forth in the lineage of H2N2 vaccines (Fig. 1C). The avirulent vaccine A/Ann Arbor/6/60 shares the highest sequence similarity (99.45%, 543/546) with the mosaic strain from position 1 to 546 among all isolates deposited in the GenBank. A CAIV-T (tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann Arbor/6/60 ([Gruber, 2002] and [Herlocher et al., 1993]) has been licensed in the US since 2003, suggesting that it might be shed by the vaccinees in the Ontario region and act as the putative minor parent of the mosaic. Therefore, we proposed that the putative minor parent of the mosaic might have descended from the lineage of the avirulent vaccine of human H2N2. This finding also suggested that the avirulent vaccine of human influenza A was able to shape the genetic diversity of the virus via homologous recombination with circulating viruses.

Please. The Nature Precedings paper showed that the regions of IDENTITY with swine from 1977 was extensive and in multiple Canadian isolates and in two genes (PB2 and PA).

The Virology papers found some of the recombination, but got the earlier parent wrong. Copied and pasted misinformation is still misinformation.
 
Re: Virology. Homologous recombination evidence in human and swine influenza A viruses.

Please. The Nature Precedings paper showed that the regions of IDENTITY with swine from 1977 was extensive and in multiple Canadian isolates and in two genes (PB2 and PA).

The Virology papers found some of the recombination, but got the earlier parent wrong. Copied and pasted misinformation is still misinformation.
Just to clarify the above. Although the Virology paper sites homology with human H2N2 isolats from the 50's and 60's, the PA and PB2 sequences in the Canadian swine had long regions of identity which exactly matched swine sequences from 1977, indicating these sequences were the true parental sequences. Moreover, there were nested regions of identity with 1998 swine sequences as well as the acquistion of 2002 swine sequences found in Korea, so there is no evidence that the human H2N2 played any role in the acquistion of swine sequences by the Canadian swine.
 
Live Vaccine and evolution of Pandemic strains via recombination.

Live Vaccine and evolution of Pandemic strains via recombination.

Homologous recombination evidence in human and swine influenza A viruses

Abstract
Dynamic gene mutation and the reassortment of genes have been considered as the key factors responsible for influenza A virus virulence and host tropism change. This study reports several significant evidence demonstrating that homologous recombination also takes place between influenza A viruses in human and swine lineages. Moreover, in a mosaic descended from swine H1N1 subtype and human H2N2, we found that its minor putative parent might be a derivative from the human cold-adapted vaccine lineage, which suggests that live vaccine is capable of playing a role in genetic change of influenza A virus via recombination with circulating viruses. These results would be important for knowing the molecular mechanism of mammal influenza A virus heredity and evolution.


Introduction:

Influenza viruses threaten significantly both human and animal health. In the last hundred years, several influenza pandemics were responsible for the deaths of at least 40 million people (Horimoto and Kawaoka, 2005). Recently, a highly pathogenic avian influenza virus (AIV; H5N1) has resulted in the death of more than 200 people and the slaughter of millions of poultry in Asia, Europe and Africa, raisingconcern over the possibility of a new influenza pandemic among the world's immunologically naive populations (Horimoto and Kawaoka,2005).

The virus belongs to the Orthomyxoviridae family and contains eight segments of single-stranded RNA (ssRNA) which encode 11 proteins, PB2, PB1, PB1-F2, PA, HA, NP, NA, M1, M2, NS1 and NS2 (Nelson and Holmes, 2007). These segments allow for the swapping and exchange of gene segments between different strains. Specifically it occurs when the human influenza viruses swap their HA glycoprotein, NA glycoprotein or polymerase (PB1, PB2, PA) segments with those of avian and pig Influenza A viruses. Although the origin of the H1N1 strain that caused the severe pandemic of 1918 is less clear and the source of much debate (Antonovics et al., 2006; Gibbs and Gibbs, 2006; Taubenberger et al., 2005), reassortment among HA and NA subtypes was fundamental in the human pandemics of 1957 (H2N2 subtype) and 1968 (H3N2 subtype), which also acquired a new basic polymerase 1 (PB1) segment (Lindstrom et al., 2004).

Live vaccine derived from an A/Leningrad/134/47/57 (H2N2) master strain, a cold-adapted H2N2 strain (Rudenko et al., 1993), has been used in Russia and other countries. Avirulent vaccine CAIV-T (tradename FluMistTM, Aviron, Mt. View, CA) derived from A/Ann Arbor/6/60 has been licensed in the US. The advent of live attenuated cold-adapted influenza virus vaccine (CAIV-T) administered intranasally may provide a convenient and effective alternative approach for influenza immunization (Gruber, 2002). However, since live vaccine strains are potentially released into the environment by vaccinees, safety issues concerning medical as well as environmental aspects must be considered. An important aspect concerns the exchange of genetic information between the vaccine of interest and another vaccine or wild-type strains of the carrier organism. Here, we found the natural recombinant which might be derived from a live vaccine strain. It suggests that live avirulent vaccine can play some and perhaps a very important role in speeding up the evolution of influenza A virus. It has been reported that a mosaic bovine viral diarrhea virus between a persisting pestivirus and a vaccine strainwas a cytopathogenic virus that induced lethal diseases (Becher et al., 2001). And there have been recent polio epidemics in Hispaniola that arose from similar recombinants involving vaccine virus and other endogenous enteroviruses, which threatens the entire WHO polio eradication program (Kew et al., 2002). Therefore, it might be necessary to evaluate the effect of various vaccine recombination on influenza A virus virulence and host tropism. From an environmental perspective, inactivated influenza A vaccine should be safer.
In conclusion, our study provided powerful evidence that intragenic recombination occurs in mammalian influenza A viruses from different species, which shows that homologous recombination may play a role in driving the evolution of mammalian influenza A viruses and has the potential to change their virulence and host tropism. Finally, our results suggest that live vaccine is capable of speeding upviral evolution via recombination with circulating viruses.
 
Re: Live Vaccine and evolution of Pandemic strains via recombination.

Re: Live Vaccine and evolution of Pandemic strains via recombination.

link?
 
Back
Top Bottom